Is BPC-157 actually found in the human body?

Yes — and that is genuinely unusual for a research peptide. BPC-157 is a fragment of a larger protein found in human gastric juice. Researchers identified it because the stomach lining survives in conditions (acid, enzymes, mechanical stress) that would destroy most tissue, and they wanted to know what protective signals were involved. The synthetic BPC-157 used in research is a copy of that natural fragment.

Why does BPC-157 seem to work on so many different tissues?

Most peptides act on one specific receptor system — lock and key. Research suggests BPC-157 is different. It seems to influence several repair-related pathways at once, including growth factor signalling, nitric oxide, and angiogenesis (new blood vessel formation). Almost every kind of tissue repair depends on these pathways, so a peptide that supports them generally appears to show activity across a wide range of tissues. Researchers are still working out the full picture.

Have any human clinical trials been completed?

No completed human clinical trials have been published. All the published research findings come from cell models and animal studies. This places BPC-157 at an earlier stage of evidence than research peptides with FDA-approved indications. Research suggests strong activity in preclinical models, but human data is the missing piece. Honest framing matters — research and clinical use are different things.

What is the relationship between BPC-157 and other healing peptides?

BPC-157 is often studied alongside TB-500 (thymosin beta-4), GHK-Cu (copper peptide), and KPV (a small alpha-MSH fragment). Each works through different mechanisms. BPC-157 supports growth factor signalling and angiogenesis. TB-500 helps cells migrate to damaged tissue. GHK-Cu shifts gene expression toward more youthful patterns. KPV calms inflammation. They are sometimes studied in combination because they appear to work on complementary pathways.

How was BPC-157 originally discovered?

Through stomach research at the University of Zagreb in the early 1990s. The Sikiric research group was investigating how gastric mucosa survives such hostile conditions. They identified a 15-amino-acid fragment of a stomach-juice protein that appeared to be doing protective work, named it Body Protection Compound 157, and over the following 30+ years built one of the most extensive preclinical research literatures of any peptide.

Research Library›Recovery & Tissue Repair›BPC-157

Body Protection Compound

BPC-157: The Complete Guide

A 15-amino-acid peptide your body already makes — found naturally in human stomach juice. One of the most extensively studied compounds in tissue repair research, with over 100 published studies behind it.

8 min read·4 studies cited·Updated April 2026

Evidence level

Preclinical only — animal and cell studies

No completed human trials published

What this level means

Quick Reference

Full Name	Body Protection Compound 157
Sequence	GEPPPGKPADDAGLV (15 amino acids)
Source	Naturally found in human gastric juice
Discovered	University of Zagreb, 1990s
Storage	Refrigerate (2–8°C)

What is BPC-157?

Here is the surprising thing about BPC-157: your body already makes it. It is a 15-amino-acid fragment of a larger protein found in human stomach juice — which is why "BPC" stands for Body Protection Compound. Researchers in Croatia identified it in the 1990s as one reason the stomach lining can survive an environment that would dissolve almost any other tissue: hydrochloric acid, digestive enzymes, constant mechanical stress.

The synthetic version researchers use today is a copy of that natural fragment. Same 15 amino acids in the same order, made in a lab to research-grade purity. The whole reason it draws attention is that the stomach is essentially a wound-healing factory running 24/7 — and BPC-157 appears to be one of the signalling molecules that runs that factory. The research question for the last three decades has been: does the same molecule support tissue repair elsewhere in the body too?

Over 100 peer-reviewed studies later, the answer is "research suggests yes, in animal models, across a surprising range of tissue types." Tendons, ligaments, muscle, bone, gut lining, blood vessels. There are no completed human clinical trials yet — all the published findings come from cell models and animal studies, primarily from the original Sikiric lab at the University of Zagreb. That is the foundation BPC-157 sits on.

Research Applications

Research on BPC-157 stretches across surprisingly different tissue types — which is part of what makes it interesting. Most peptides act on one receptor system; research suggests BPC-157 influences several pathways involved in repair. Here is where the published research has focused:

🦴

Tendons and Ligaments

Tendons heal slowly because they have very limited blood supply — the cells that do the repair work struggle to reach the damage. Research suggests BPC-157 may help tendon and ligament fibroblasts (the building-block cells) function and migrate more effectively in healing models.

🫀

Gut and Stomach Lining

This is BPC-157's home territory — the tissue it was originally found in. Research models examining ulcers, intestinal damage, and inflammatory gut conditions consistently show interest in BPC-157, which makes sense given that stomach juice is where the natural version lives.

🧬

Blood Vessel Formation

When tissue is injured, new blood vessels need to grow in to deliver nutrients and oxygen to the repair site. This process is called angiogenesis. Research suggests BPC-157 supports angiogenesis — one mechanism that may explain why it appears active across so many different tissue types.

💪

Muscle Tissue

Skeletal muscle injuries, from minor strains to more serious tears, depend on satellite cells (muscle stem cells) waking up and rebuilding. Research suggests BPC-157 may influence this repair signalling in animal models.

🦴

Bone Healing

Bone repair is a slow, sequential process — inflammation, soft callus formation, hard callus, remodelling. Research models examining each stage have included BPC-157 as a study compound, particularly in the early inflammation and angiogenesis phases.

🧠

Nervous System Research

A more recent research direction. Some studies have examined BPC-157 in models of nerve injury and neurotransmitter modulation. Research suggests effects on dopamine and serotonin pathways in animal models, though this area is less developed than the tissue-repair literature.

How BPC-157 Works

The honest answer first: the full mechanism is still being worked out. Research suggests BPC-157 influences several pathways at once rather than acting on a single receptor — which is unusual for a peptide and is part of why characterising it has taken decades. Here are the main mechanisms the published literature has identified.

Growth factor signalling: Think of growth factors as the "build-here" signals your body sends to a repair site — molecules like VEGF (which builds blood vessels), FGF (which builds tissue), and EGF (which supports cell growth). Research suggests BPC-157 increases the activity of these factors and the receptors they bind to. The peptide may not be doing the building itself — it may be amplifying signals that are already there.

The nitric oxide pathway: Nitric oxide is a tiny molecule with a huge job — it dilates blood vessels, controls blood flow, and is heavily involved in healing. Research suggests BPC-157 interacts with this pathway in ways that may help support blood flow to damaged tissue, which is essential for any kind of repair.

Angiogenesis — new blood vessel formation: When tissue is damaged, the area needs a new blood supply to heal. Research suggests BPC-157 supports the formation of new blood vessels into damaged areas. This single mechanism may explain a lot of what BPC-157 appears to do across different tissues — because almost every kind of healing depends on getting blood flow to the right place at the right time.

Stability in the body: Most peptides break down in minutes when you put them into the body. Research suggests BPC-157 is unusually stable — it survives in gastric juice (which makes sense, given where it comes from) and appears to remain active longer than most peptide research compounds. That stability is part of why it has become such a workhorse tool in tissue-repair research.

Storage Guidelines

Store at 2–8°C in a cool, dry place. Protect from light and moisture. Refrigerate once in solution form.

Frequently Asked Questions

Technical Specifications

Full Name	Body Protection Compound 157
Sequence	Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Amino Acid Count	15
Molecular Formula	C₆₂H₉₈N₁₆O₂₂
Molecular Weight	~1419.55 g/mol
Source	Fragment of natural gastric juice protein
Appearance	White lyophilised powder
Solubility	Soluble in water
Storage (Powder)	2–8°C refrigerated, -20°C long-term
Storage (Solution)	2–8°C, do not freeze
Origin	University of Zagreb (Sikiric lab)

Compiled by the Southern Pacific Labs research team. Last updated April 2026.

Browse the research range →

Published References

Sikiric P, Seiwerth S, Rucman R, et al. “Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157.” Current pharmaceutical design, 2013. PubMed
A foundational review by the original discovery lab, summarising 20+ years of BPC-157 research on protecting the gut lining from common anti-inflammatory drug damage in animal models.
Chang CH, Tsai WC, Lin MS, et al. “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.” Journal of applied physiology (Bethesda, Md. : 1985), 2011. PubMed
One of the most-cited tendon-repair studies. Examined tendon fibroblast behaviour and showed BPC-157 supported tendon healing markers in cell-culture and animal models.
Krivic A, Anic T, Seiwerth S, et al. “Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: Promoted tendon-to-bone healing and opposed corticosteroid aggravation.” Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2006. PubMed
Looked at how a torn Achilles tendon heals in rats and how BPC-157 affected the recovery process. The animal-model basis for much of the tendon-healing research that followed.
Seiwerth S, Rucman R, Turkovic B, et al. “BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing.” Current pharmaceutical design, 2018. PubMed
A comprehensive review by the Sikiric group connecting BPC-157 to the broader field of growth-factor research and angiogenesis (new blood vessel formation) across multiple tissue types.

Browse all BPC-157 research on PubMed →